Bhatt, D. L., & Hacke, W. (2005). A global view of atherothrombosis: Baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. American heart journal, 150(3), .
Chicago Style (17th ed.) CitationBhatt, Deepak L., and Werner Hacke. "A Global View of Atherothrombosis: Baseline Characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial." American Heart Journal 150, no. 3 (2005).
MLA (9th ed.) CitationBhatt, Deepak L., and Werner Hacke. "A Global View of Atherothrombosis: Baseline Characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial." American Heart Journal, vol. 150, no. 3, 2005.